Promising—but controlled trials are still needed.
#Hepatology #ACLF #AlcoholAssociatedHepatitis #PLEX #LiverDisease #ClinicalEvidence #MedSky
Promising—but controlled trials are still needed.
#Hepatology #ACLF #AlcoholAssociatedHepatitis #PLEX #LiverDisease #ClinicalEvidence #MedSky
Published in HEPATOLOGY, a new framework from AASLD and four international liver societies aligns ACLF diagnosis, management, liver transplantation, and research.
📗 https://bit.ly/4BulOK1
Published in HEPATOLOGY, a new framework from AASLD and four international liver societies aligns ACLF diagnosis, management, liver transplantation, and research.
📗 https://bit.ly/4BulOK1
www.youtube.com/watch?v=YTsD...
www.youtube.com/watch?v=YTsD...
🩺 ALB-TRIAL wrap-up, #biomarkers, #POC biosensors & key decisions on data, #IP + exploitation 👩🔬
🫶 A heartfelt thank you to SEAB member Prof. Tilman Sauerbruch for his unwavering support throughout the years!
#cirrhosis #ACLF
@medblab.bsky.social
🩺 ALB-TRIAL wrap-up, #biomarkers, #POC biosensors & key decisions on data, #IP + exploitation 👩🔬
🫶 A heartfelt thank you to SEAB member Prof. Tilman Sauerbruch for his unwavering support throughout the years!
#cirrhosis #ACLF
@medblab.bsky.social
🥳 Jonel Trebicka opened #MICROB-PREDICT's Final GA Meeting today, looking back on 7 years of research, 100+ publications & major achievements.
Now it’s time for the final push! 🔬👏
#ACLF #cirrhosis #microbiome
@medblab.bsky.social
🥳 Jonel Trebicka opened #MICROB-PREDICT's Final GA Meeting today, looking back on 7 years of research, 100+ publications & major achievements.
Now it’s time for the final push! 🔬👏
#ACLF #cirrhosis #microbiome
@medblab.bsky.social
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
Our final newsletter highlights the project's achievements, dissemination activities & new publications: mailchi.mp/1600401b049d...
The commitment to advance G-TAK beyond A-TANGO and help #cirrhosis & #ACLF patients remains strong. 💪
Our final newsletter highlights the project's achievements, dissemination activities & new publications: mailchi.mp/1600401b049d...
The commitment to advance G-TAK beyond A-TANGO and help #cirrhosis & #ACLF patients remains strong. 💪
www.youtube.com/watch?v=AClf...
www.youtube.com/watch?v=AClf...
Find out more 👉️ buff.ly/XXGuEnP
#GISky #ACLF
Find out more 👉️ buff.ly/XXGuEnP
#GISky #ACLF
#ACLF #Infection
🔗 www.xiahepublishing.com/2310-8819/JC...
#ACLF #Infection
🔗 www.xiahepublishing.com/2310-8819/JC...
. Cr >5 unlikely to benefit
. Volume overloaded or those with 3 or more organ failures (ACLF-3) at high risk for respiratory failure
. Do not give is spO2 is or becomes under 90% #LiverTwitter
. Cr >5 unlikely to benefit
. Volume overloaded or those with 3 or more organ failures (ACLF-3) at high risk for respiratory failure
. Do not give is spO2 is or becomes under 90% #LiverTwitter
Join @OHIOLIVER for our annual liver meeting update. Speakers include @aderlinder @metrohealthCLE and a special state of the art lecture on #ACLF by @CLindenmeyerMD @ClevelandClinic
#livertwitter
Join @OHIOLIVER for our annual liver meeting update. Speakers include @aderlinder @metrohealthCLE and a special state of the art lecture on #ACLF by @CLindenmeyerMD @ClevelandClinic
#livertwitter
http://medrxiv.org/cgi/content/short/2025.02.04.25321370v1
http://medrxiv.org/cgi/content/short/2025.02.04.25321370v1
Haemin Lee, Ishana Tripathi, and Xingguang Zou - emerging issues in corporate governance - www.youtube.com/watch?v=BcHm... (3/7)
Haemin Lee, Ishana Tripathi, and Xingguang Zou - emerging issues in corporate governance - www.youtube.com/watch?v=BcHm... (3/7)